Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Suspended 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Burkitt Lymphoma 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, Large B-Cell, Diffuse 19Lymphoma, Follicular 12Lymphoma 11Rhabdomyosarcoma 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Recurrence 7Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Biphenotypic, Acute 7Sarcoma, Ewing 6Lymphoma, Non-Hodgkin 6Lymphoma, B-Cell 6Neuroblastoma 5Neoplasms 5Lymphoma, Mantle-Cell 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia 4Wilms Tumor 3Rhabdomyosarcoma, Embryonal 3Osteosarcoma 3Lymphoproliferative Disorders 3Lymphoma, T-Cell 3Down Syndrome 3Sarcoma 2Rhabdomyosarcoma, Alveolar 2Rhabdoid Tumor 2Medulloblastoma 2Lymphoma, T-Cell, Peripheral 2

Interventions

Doxorubicin 14pembrolizumab 11Specimen Handling 11Magnetic Resonance Spectroscopy 10Biopsy 9Cyclophosphamide 8X-Rays 7Radiotherapy 7Nivolumab 7Ifosfamide 7Phantoms, Imaging 6Gemcitabine 6liposomal doxorubicin 5Temozolomide 5Radiation 5tazemetostat 4palbociclib 4Trabectedin 4Nuclear Medicine Department, Hospital 4Irinotecan 4Ipilimumab 4pazopanib 3larotrectinib 3fludarabine 3cabozantinib 3atezolizumab 3Surveys and Questionnaires 3Radiation Dose Hypofractionation 3Proton Therapy 3Carboplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma × Vincristine × 90 days × Clear all
NCT00077285 2026-05-22

Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
65 enrolled
Sarcoma

Malignant mesenchymal tumor, Rhabdomyosarcoma, Sarcoma

NCT04890093 2026-03-16

Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1/2 Suspended
64 enrolled
Sarcoma

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡